Radiopharm Theranostics Partners with Siemens on RAD101 PET Imaging Agent for Brain Metastases
Radiopharm Theranostics and Siemens Healthineers sign manufacturing supply agreement for RAD101 PET imaging agent, advancing toward Phase 3 trial with strong interim data.
SMMNYRADXradiopharmaceuticalsPET imaging